Stroke Trial, Recruiting (NCT07410624)

Stroke Trial, Recruiting NCT07410624 Sponsor: University of Alberta Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT07410624 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People between 18 and 85 years of age
People who have been admitted to an intensive care unit (ICU) at one of the hospitals taking part in this trial
People who have been diagnosed with one of the following conditions: a bleed around the brain (subarachnoid haemorrhage), a brain injury caused by trauma, a bleed within the brain (intracerebral haemorrhage), meningitis, seizures that do not stop on their own (status epilepticus), or an ischemic stroke (a stroke caused by a blocked blood vessel)
People for whom informed consent has been provided
People who already have a urinary catheter (a thin tube used to drain urine) in place at the time of consent, which is needed to collect urine samples during the trial

Who may not be able to join:

People who are currently incarcerated
People whose stay in the ICU is expected to last less than 72 hours, as this would not allow enough time for monitoring

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sherif H Mahmoud, BSc (Pharm), MSc, PhD, FNCS, University of Alberta

Phone: 780.492.5364

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07410624

Sponsor: University of Alberta

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: 780.492.5364

More information: https://clinicaltrials.gov/study/NCT07410624

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People between 18 and 85 years of age
People who have been admitted to an intensive care unit (ICU) at one of the hospitals taking part in this trial
People who have been diagnosed with one of the following conditions: a bleed around the brain (subarachnoid haemorrhage), a brain injury caused by trauma, a bleed within the brain (intracerebral haemorrhage), meningitis, seizures that do not stop on their own (status epilepticus), or an ischemic stroke (a stroke caused by a blocked blood vessel)
People for whom informed consent has been provided
People who already have a urinary catheter (a thin tube used to drain urine) in place at the time of consent, which is needed to collect urine samples during the trial

Who may not be able to join:

People who are currently incarcerated
People whose stay in the ICU is expected to last less than 72 hours, as this would not allow enough time for monitoring

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Alberta

Registry

ClinicalTrials.gov

Start date

1 October 2021

Est. completion

30 September 2026

Where this trial is recruiting

🇨🇦 Canada 🇺🇸 United States

Primary endpoints

CrCl Measurements; Drug Concentration Determination

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov